Tissue Regenix Group plc

TRX.L · LSE
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents£1,870£4,650£4,946£5,692
Short-Term Investments£0£0£0£0
Receivables£4,380£3,681£4,326£4,021
Inventory£14,006£10,358£9,046£7,176
Other Curr. Assets£1,014£401£0-£599
Total Curr. Assets£21,270£19,090£18,318£16,289
Property Plant & Equip (Net)£8,309£9,018£7,435£6,716
Goodwill£11,587£11,587£9,633£8,555
Intangibles£4,180£1,621£12,521£11,122
Long-Term Investments£0£0£0£0
Tax Assets£0£0£0£0
Other NC Assets£0£1,927-£9,633-£8,555
Total NC Assets£24,076£24,153£19,955£17,837
Other Assets£0£0£0£0
Total Assets£45,346£43,243£38,273£34,127
Liabilities
Payables£2,714£1,207£1,075£2,574
Short-Term Debt£610£642£1,134£118
Tax Payable£636£243£39£51
Deferred Revenue£0£0£0£0
Other Curr. Liab.£2,195£2,643£4,396£477
Total Curr. Liab.£6,155£4,735£6,644£3,220
LT Debt£9,855£8,753£8,474£7,829
Deferred Rev, NC£0£0£0£0
Deferred Tax Liab, NC£280£400£520£640
Other NC Liab.£0£0£0£0
Total NC Liab.£10,135£9,153£8,994£8,469
Other Liabilities£0£0£0£0
Cap. Leases£186£3,410£3,350£3,482
Total Liabilities£16,290£13,888£13,000£9,473
Equity
Pref Stock£0£29,470£0£0
Common Stock£92£91£9,167£11,774
Retained Earnings-£124,095-£123,764-£122,129-£84,750
AOCI£20,723-£529£11,292£198
Other Equity£133,099£132,996£132,922£98,133
Total Equity£29,819£30,150£31,252£25,355
Supplemental Information
Minority Interest-£763-£624-£707-£701
Total Liab. & Tot. Equity£45,346£43,243£38,273£34,127
Net Debt£8,595£4,745£4,662£2,255
Tissue Regenix Group plc (TRX.L) Financial Statements & Key Stats | AlphaPilot